Volume 65 • 2004 • Supplement 4

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Introduction. Pharmacologic Treatments of Major Depression: Are Two Mechanisms Really Better Than One? [Free]

J Clin Psychiatry 2004;65(suppl 4):3-4

Selectivity of Antidepressants: From the Monoamine Hypothesis of Depression to the SSRI Revolution and Beyond

J Clin Psychiatry 2004;65(suppl 4):5-10

Distinguishing Roles for Norepinephrine and Serotonin in the Behavioral Effects of Antidepressant Drugs

J Clin Psychiatry 2004;65(suppl 4):11-24

How Antidepressants Help Depression: Mechanisms of Action and Clinical Response

J Clin Psychiatry 2004;65(suppl 4):25-30

Are Two Antidepressant Mechanisms Better Than One? Issues in Clinical Trial Design and Analysis

J Clin Psychiatry 2004;65(suppl 4):31-36

Selective Versus Multi-Transmitter Antidepressants: Are Two Mechanisms Better Than One?

J Clin Psychiatry 2004;65(suppl 4):37-45

Newer Antidepressants: Review of Efficacy and Safety of Escitalopram and Duloxetine

J Clin Psychiatry 2004;65(suppl 4):46-52

Remission Versus Response: The New Gold Standard of Antidepressant Care

J Clin Psychiatry 2004;65(suppl 4):53-59

Debate and Discussion: In the Treatment of Depression, Does Selectivity of Action Matter? [Free]

J Clin Psychiatry 2004;65(suppl 4):60-62